We encourage you to join us for the first IMol Science Club seminar after the summer break. On Friday, August 25, we will host Peter Sicinski from the Department of Genetics, Harvard Medical School, who will give a lecture entitled “Targeting cyclin-dependent kinase 2 (CDK2) for cancer treatment”
Our guest is a professor of genetics at Harvard Medical School. His laboratory at Dana-Farber Cancer Institute studies the role of cell cycle machinery in normal cell proliferation and in oncogenesis using mouse genetic, genomic, proteomic and systems biology approaches.
August 25th, 9:30 AM CET
IMol conference room, Flisa street no 6, Warsaw
Peter Sicinski
Targeting cyclin-dependent kinase 2 (CDK2) for cancer treatment
The seminar is open to the public. More information and registration form: https://www.imol.institute/imol-science-club